Status:
COMPLETED
Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus
Lead Sponsor:
Boston University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
21-75 years
Phase:
NA
Brief Summary
The present study is designed to test the hypothesis that resveratrol supplementation will improve the function of the endothelium in patients with type 2 diabetes mellitus. The function of the endot...
Eligibility Criteria
Inclusion
- Male and female subjects
- Age over 21 years old
- Body mass index less than 38 kg/m2
- Clinical stable type 2 diabetes mellitus
Exclusion
- Women who are lactating or pregnant
- Treatment with an investigations product within 30 days of screening
- Clinically evident major illness of other organ systems, including cancer, renal failure, or other conditions in the opinion of the investigators that would make clinical study inappropriate
- Liver transaminase levels greater than 3 times the upper limit of normal
- History of psychological illness or condition that would interfere with the subject's ability to understand the requirements of the study
- Vitamin supplements exceeding two times the recommended daily allowance
- Resveratrol or other dietary supplements except for a daily multivitamin
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT01881347
Start Date
January 1 2013
End Date
July 1 2016
Last Update
March 1 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University Medical Center
Boston, Massachusetts, United States, 02118